CRIZOTINIB

CRIZOTINIB was reported 12739 times

CRIZOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEOBRONCHITIS VIRAL 4 0.2353
1 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT 3 0.1071
2 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 6 0.0909
3 LEPTOTRICHIA INFECTION 4 0.0889
4 TRACHEAL CANCER 4 0.0714
5 RENAL CYST INFECTION 11 0.0692
6 NON-SMALL CELL LUNG CANCER STAGE IV 25 0.0685
7 RENAL HYDROCELE 4 0.0667
8 LUNG ADENOCARCINOMA STAGE IV 25 0.0656
9 TRACHEAL INFLAMMATION 7 0.0642
10 NON-SMALL CELL LUNG CANCER 287 0.0599
11 NON-SMALL CELL LUNG CANCER METASTATIC 52 0.0592
12 DRUG RESISTANCE MUTATION 10 0.0562
13 RENAL ABSCESS 46 0.0562
14 LUNG ADENOCARCINOMA METASTATIC 11 0.0472
15 INFLAMMATORY MYOFIBROBLASTIC TUMOUR 6 0.0462
16 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 3 0.0349
17 VISUAL PERSEVERATION 5 0.0340
18 INTRACRANIAL INFECTION 4 0.0320
19 NEOPLASM PROGRESSION 1110 0.0319
20 ACQUIRED GENE MUTATION 40 0.0305
21 ADENOCARCINOMA METASTATIC 6 0.0291
22 LUNG ADENOCARCINOMA 87 0.0289
23 ALBUMIN GLOBULIN RATIO DECREASED 6 0.0259
24 PHOTOPSIA 135 0.0213
25 NEUROBLASTOMA 8 0.0209
26 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 6 0.0205
27 PLEURAL THICKENING 14 0.0205
28 CEREBRAL ASPERGILLOSIS 12 0.0195
29 VASOGENIC CEREBRAL OEDEMA 14 0.0194
30 HYDROTHORAX 16 0.0193
31 VISUAL BRIGHTNESS 7 0.0177
32 EGFR GENE MUTATION 6 0.0160
33 OESOPHAGEAL INFECTION 7 0.0157
34 CARCINOEMBRYONIC ANTIGEN INCREASED 29 0.0150
35 CEREBRAL FUNGAL INFECTION 4 0.0141
36 METAPNEUMOVIRUS INFECTION 11 0.0140
37 BRONCHIAL CARCINOMA 11 0.0140
38 MYOCARDIAL NECROSIS MARKER INCREASED 22 0.0131
39 LUNG CANCER METASTATIC 36 0.0125
40 RADIATION NECROSIS 7 0.0122
41 LYMPHANGIOSIS CARCINOMATOSA 12 0.0115
42 METASTASES TO CENTRAL NERVOUS SYSTEM 145 0.0112
43 LYMPHANGITIS 9 0.0112
44 GLOBULINS INCREASED 4 0.0110
45 PULMONARY ARTERY THROMBOSIS 8 0.0104
46 DISEASE PROGRESSION 1217 0.0103
47 OESOPHAGITIS ULCERATIVE 7 0.0102
48 LUNG NEOPLASM MALIGNANT 420 0.0102
49 NECROTISING OESOPHAGITIS 5 0.0100
50 MONOCYTE PERCENTAGE INCREASED 7 0.0099
51 NEUTROPHIL PERCENTAGE DECREASED 5 0.0094
52 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
53 OESOPHAGITIS 100 0.0091
54 BRONCHOSTENOSIS 5 0.0091
55 METASTASES TO ADRENALS 8 0.0087
56 OESOPHAGEAL ULCER 33 0.0086
57 SECOND PRIMARY MALIGNANCY 70 0.0084
58 MALIGNANT PLEURAL EFFUSION 14 0.0083
59 AXILLARY VEIN THROMBOSIS 3 0.0081
60 MULTIPLE-DRUG RESISTANCE 25 0.0081
61 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 4 0.0080
62 OESOPHAGEAL DISCOMFORT 6 0.0079
63 METASTASES TO MENINGES 18 0.0079
64 VITREOUS FLOATERS 76 0.0077
65 HYPOPROTEINAEMIA 14 0.0074
66 FUNGAL OESOPHAGITIS 5 0.0071
67 OESOPHAGEAL PAIN 28 0.0071
68 GENE MUTATION 14 0.0071
69 RENAL CYST 54 0.0068
70 MEAN PLATELET VOLUME INCREASED 4 0.0066
71 PSOAS ABSCESS 4 0.0064
72 MUSCLE ABSCESS 4 0.0064
73 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 5 0.0064
74 SINUS BRADYCARDIA 61 0.0063
75 BLOOD ALBUMIN DECREASED 50 0.0063
76 HYPOALBUMINAEMIA 49 0.0063
77 PRODUCT MONITORING ERROR 9 0.0062
78 EMBOLISM 51 0.0061
79 OESOPHAGEAL CANDIDIASIS 24 0.0060
80 AMAUROSIS 5 0.0059
81 PARANEOPLASTIC SYNDROME 4 0.0059
82 PNEUMONITIS 155 0.0057
83 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 7 0.0056
84 SUSPECTED OFF LABEL USE 24 0.0053
85 HALO VISION 6 0.0053
86 SUBCLAVIAN VEIN THROMBOSIS 6 0.0053
87 LYMPHOCYTE PERCENTAGE DECREASED 7 0.0052
88 CREATINE KINASE INCREASED 4 0.0052
89 PLEURAL EFFUSION 314 0.0052
90 PROTEIN TOTAL DECREASED 19 0.0050
91 GASTROINTESTINAL TOXICITY 24 0.0050
92 RETICULOCYTE COUNT INCREASED 4 0.0049
93 DRUG RESISTANCE 125 0.0049
94 PERICARDIAL EFFUSION 111 0.0048
95 MEAN PLATELET VOLUME DECREASED 4 0.0048
96 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 16 0.0047
97 TUMOUR NECROSIS 5 0.0047
98 NEOPLASM RECURRENCE 16 0.0047
99 HEPATIC CYST 16 0.0047
100 SARCOMA 5 0.0044
101 HEPATITIS FULMINANT 13 0.0044
102 VENOUS THROMBOSIS LIMB 9 0.0044
103 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0043
104 TRANSAMINASES INCREASED 95 0.0043
105 ALVEOLITIS 6 0.0042
106 CHYLOTHORAX 3 0.0042
107 VISUAL FIELD DEFECT 30 0.0041
108 AMYLASE INCREASED 15 0.0041
109 BLOOD CHLORIDE INCREASED 7 0.0040
110 HEPATOTOXICITY 89 0.0040
111 GENERALISED OEDEMA 49 0.0040
112 BLOOD BILIRUBIN ABNORMAL 5 0.0039
113 MEAN CELL VOLUME DECREASED 6 0.0039
114 METASTASES TO PLEURA 4 0.0038
115 OEDEMA 204 0.0038
116 HYPERTRANSAMINASAEMIA 26 0.0037
117 HEPATIC FUNCTION ABNORMAL 139 0.0037
118 BODY MASS INDEX INCREASED 5 0.0037
119 OEDEMA PERIPHERAL 449 0.0037
120 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
121 CARDIOPULMONARY FAILURE 14 0.0036
122 EROSIVE OESOPHAGITIS 6 0.0035
123 INTERSTITIAL LUNG DISEASE 170 0.0035
124 BRAIN OPERATION 8 0.0035
125 LIP ULCERATION 4 0.0034
126 NEUTROPENIC COLITIS 7 0.0034
127 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
128 ODYNOPHAGIA 20 0.0033
129 NEOPLASM MALIGNANT 222 0.0033
130 OPTIC NEUROPATHY 7 0.0033
131 VARICES OESOPHAGEAL 10 0.0033
132 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
133 VISUAL IMPAIRMENT 406 0.0033
134 RADIATION PNEUMONITIS 7 0.0033
135 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
136 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
137 PERFORMANCE STATUS DECREASED 15 0.0032
138 OSTEOSCLEROSIS 5 0.0032
139 OESOPHAGEAL STENOSIS 9 0.0032
140 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
141 ADENOCARCINOMA 7 0.0031
142 SCLERITIS 5 0.0031
143 ELECTROCARDIOGRAM QT PROLONGED 111 0.0031
144 MALIGNANT NEOPLASM PROGRESSION 316 0.0031
145 EARLY SATIETY 6 0.0031
146 FOREIGN BODY IN RESPIRATORY TRACT 4 0.0030
147 VOCAL CORD DISORDER 6 0.0030
148 TUMOUR PAIN 4 0.0030
149 CELL DEATH 6 0.0030
150 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
151 LIVER FUNCTION TEST INCREASED 62 0.0029
152 ALANINE AMINOTRANSFERASE INCREASED 176 0.0029
153 LUNG INFECTION 44 0.0028
154 SKIN TOXICITY 16 0.0028
155 CEREBRAL THROMBOSIS 8 0.0028
156 ATELECTASIS 27 0.0028
157 VOCAL CORD PARALYSIS 5 0.0028
158 SYSTEMIC CANDIDA 7 0.0028
159 ASPARTATE AMINOTRANSFERASE INCREASED 148 0.0028
160 ERYSIPELAS 14 0.0028
161 HEPATITIS 71 0.0028
162 LIVER ABSCESS 9 0.0028
163 DEATH 2379 0.0028
164 DYSGEUSIA 205 0.0028
165 ILEUS 34 0.0027
166 PARONYCHIA 12 0.0027
167 CARDIAC FIBRILLATION 4 0.0027
168 CACHEXIA 14 0.0027
169 AORTIC ARTERIOSCLEROSIS 7 0.0027
170 OESOPHAGEAL SPASM 5 0.0027
171 CHOLANGIOCARCINOMA 4 0.0027
172 BLOOD CHOLESTEROL DECREASED 5 0.0027
173 INFECTIOUS PLEURAL EFFUSION 4 0.0026
174 OESOPHAGEAL DISORDER 10 0.0026
175 HAEMANGIOMA 6 0.0026
176 BILIRUBIN CONJUGATED INCREASED 6 0.0026
177 HYPOGEUSIA 5 0.0025
178 BLOOD ALKALINE PHOSPHATASE INCREASED 63 0.0025
179 PLEURISY 15 0.0025
180 EMPYEMA 5 0.0025
181 LACUNAR INFARCTION 6 0.0025
182 METASTASES TO LIVER 44 0.0025
183 OPTIC NERVE DISORDER 4 0.0025
184 NIGHT BLINDNESS 4 0.0025
185 BRADYCARDIA 132 0.0025
186 LIPASE INCREASED 19 0.0025
187 LIVER FUNCTION TEST ABNORMAL 72 0.0025
188 HEPATOCELLULAR INJURY 35 0.0025
189 HEPATITIS ACUTE 16 0.0025
190 RENAL HAEMORRHAGE 5 0.0025
191 HEART RATE DECREASED 85 0.0024
192 HAEMOPTYSIS 67 0.0024
193 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
194 CANCER PAIN 6 0.0023
195 VITREOUS DETACHMENT 5 0.0023
196 HEPATITIS TOXIC 6 0.0023
197 VENOUS THROMBOSIS 9 0.0023
198 PROSTATOMEGALY 9 0.0023
199 LUNG OPACITY 6 0.0023
200 RENAL IMPAIRMENT 191 0.0023
201 GASTROINTESTINAL OEDEMA 4 0.0023
202 METASTASES TO LUNG 26 0.0022
203 BLOOD CALCIUM DECREASED 25 0.0022
204 HEPATIC ENZYME ABNORMAL 11 0.0022
205 MONOCYTE COUNT INCREASED 8 0.0022
206 HEPATIC CYTOLYSIS 28 0.0022
207 DIPLOPIA 57 0.0022
208 BLOOD CREATININE INCREASED 143 0.0022
209 SOFT TISSUE INFECTION 4 0.0022
210 SINUS NODE DYSFUNCTION 4 0.0022
211 LYMPHOEDEMA 15 0.0022
212 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
213 PNEUMOPERITONEUM 4 0.0022
214 NEUROLOGICAL DECOMPENSATION 5 0.0022
215 LUNG CONSOLIDATION 6 0.0021
216 BRAIN OEDEMA 27 0.0021
217 BRONCHIAL OBSTRUCTION 3 0.0021
218 FAILURE TO THRIVE 11 0.0021
219 AUDITORY DISORDER 3 0.0021
220 URINARY HESITATION 5 0.0021
221 HEPATIC LESION 9 0.0021
222 PHOTOPHOBIA 39 0.0021
223 LOCAL SWELLING 36 0.0021
224 HYPOXIA 72 0.0020
225 PYELONEPHRITIS ACUTE 4 0.0020
226 CONSTIPATION 442 0.0020
227 METASTASES TO BONE 33 0.0020
228 LARGE INTESTINAL STENOSIS 4 0.0020
229 FOREIGN BODY 8 0.0020
230 PAPILLOEDEMA 9 0.0020
231 PULMONARY OEDEMA 89 0.0020
232 LYMPHOPENIA 28 0.0020
233 PULMONARY TOXICITY 14 0.0020
234 AGE-RELATED MACULAR DEGENERATION 3 0.0020
235 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
236 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
237 GASTROINTESTINAL PERFORATION 8 0.0019
238 SUBILEUS 4 0.0019
239 LIVER DISORDER 85 0.0019
240 PERIPHERAL SWELLING 294 0.0019
241 DYSPHAGIA 181 0.0019
242 ASCITES 56 0.0019
243 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
244 GASTROINTESTINAL STROMAL TUMOUR 5 0.0019
245 BLOOD SODIUM INCREASED 5 0.0019
246 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
247 RASH MORBILLIFORM 5 0.0018
248 RESPIRATORY RATE INCREASED 16 0.0018
249 PULMONARY EMBOLISM 171 0.0018
250 PNEUMOCYSTIS JIROVECI PNEUMONIA 4 0.0018
251 NEUTROPHIL COUNT DECREASED 73 0.0018
252 BRAIN NEOPLASM MALIGNANT 8 0.0018
253 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
254 METASTASES TO LYMPH NODES 12 0.0018
255 HEPATIC ENZYME INCREASED 121 0.0018
256 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
257 PNEUMATOSIS INTESTINALIS 5 0.0018
258 CEREBRAL ISCHAEMIA 9 0.0017
259 DUODENAL ULCER HAEMORRHAGE 5 0.0017
260 ENTEROCOLITIS 10 0.0017
261 LOCALISED OEDEMA 8 0.0017
262 LARGE INTESTINE PERFORATION 12 0.0017
263 HEPATIC FAILURE 52 0.0017
264 VOMITING 799 0.0017
265 HYPERCHLORHYDRIA 10 0.0017
266 VOLVULUS 4 0.0017
267 CARDIAC TAMPONADE 8 0.0017
268 METASTASIS 12 0.0017
269 DEEP VEIN THROMBOSIS 109 0.0017
270 FEEDING DISORDER 34 0.0017
271 CENTRAL NERVOUS SYSTEM LESION 23 0.0017
272 PROTHROMBIN TIME PROLONGED 10 0.0017
273 LIVER INJURY 41 0.0017
274 APPETITE DISORDER 11 0.0017
275 HYPERPYREXIA 7 0.0017
276 PULMONARY THROMBOSIS 18 0.0016
277 DECREASED APPETITE 383 0.0016
278 EMBOLISM VENOUS 5 0.0016
279 MYELOSUPPRESSION 59 0.0016
280 BRAIN NEOPLASM 15 0.0016
281 EYE OEDEMA 4 0.0016
282 METASTATIC NEOPLASM 7 0.0016
283 RETROPERITONEAL HAEMORRHAGE 4 0.0016
284 DIASTOLIC DYSFUNCTION 5 0.0016
285 ORGANISING PNEUMONIA 8 0.0016
286 BLOOD UREA INCREASED 27 0.0016
287 RESPIRATORY FAILURE 116 0.0016
288 BLOOD CREATINE INCREASED 7 0.0016
289 PNEUMOTHORAX 25 0.0016
290 GASTROENTERITIS 23 0.0016
291 EATING DISORDER 33 0.0015
292 ELECTROLYTE IMBALANCE 18 0.0015
293 AGEUSIA 38 0.0015
294 BLOOD THYROID STIMULATING HORMONE INCREASED 14 0.0015
295 OTITIS MEDIA 5 0.0015
296 CEREBRAL ATROPHY 6 0.0015
297 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
298 CARDIAC FAILURE ACUTE 10 0.0015
299 DRUG-INDUCED LIVER INJURY 47 0.0015
300 MENINGITIS 10 0.0015
301 ORTHOSTATIC HYPOTENSION 26 0.0015
302 BONE MARROW FAILURE 30 0.0015
303 CARDIAC FAILURE 118 0.0015
304 GASTRIC PERFORATION 4 0.0015
305 BLOOD TESTOSTERONE DECREASED 10 0.0015
306 CHEST INJURY 3 0.0014
307 BLOOD CREATININE ABNORMAL 5 0.0014
308 ENCEPHALITIS 10 0.0014
309 ACIDOSIS 11 0.0014
310 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
311 NAUSEA 1124 0.0014
312 TUMOUR HAEMORRHAGE 4 0.0014
313 BONE LESION 5 0.0014
314 BLOOD URIC ACID INCREASED 8 0.0014
315 MUCOSAL INFLAMMATION 36 0.0014
316 PULMONARY PAIN 4 0.0014
317 BLOOD BILIRUBIN INCREASED 37 0.0014
318 PHLEBITIS 7 0.0014
319 HYPERTRIGLYCERIDAEMIA 8 0.0014
320 THROMBOCYTOSIS 5 0.0014
321 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
322 LEUKOENCEPHALOPATHY 5 0.0013
323 MALNUTRITION 15 0.0013
324 STOMATITIS 81 0.0013
325 FEBRILE NEUTROPENIA 88 0.0013
326 DIARRHOEA 849 0.0013
327 HYPONATRAEMIA 74 0.0013
328 CEREBRAL INFARCTION 32 0.0013
329 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
330 FIBROSIS 4 0.0013
331 HYPOPHAGIA 33 0.0013
332 VISION BLURRED 175 0.0013
333 NON-CARDIAC CHEST PAIN 4 0.0013
334 HEPATITIS B REACTIVATION 4 0.0013
335 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
336 PULMONARY FIBROSIS 24 0.0012
337 DYSPEPSIA 123 0.0012
338 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
339 ACUTE RESPIRATORY FAILURE 24 0.0012
340 OCULAR DISCOMFORT 14 0.0012
341 FACE OEDEMA 21 0.0012
342 CYSTITIS HAEMORRHAGIC 5 0.0012
343 GUILLAIN-BARRE SYNDROME 6 0.0012
344 DIZZINESS POSTURAL 12 0.0012
345 BLOOD POTASSIUM INCREASED 20 0.0012
346 BREATH ODOUR 3 0.0012
347 FLUID RETENTION 62 0.0012
348 HYPERURICAEMIA 5 0.0012
349 DEHYDRATION 162 0.0012
350 HAEMATOCRIT DECREASED 24 0.0012
351 SPINAL COMPRESSION FRACTURE 10 0.0012
352 CYTOLYTIC HEPATITIS 4 0.0012
353 NEPHRITIS 4 0.0012
354 METASTASES TO SPINE 4 0.0012
355 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
356 WOUND DEHISCENCE 4 0.0012
357 MUSCULOSKELETAL CHEST PAIN 18 0.0012
358 GENERAL PHYSICAL HEALTH DETERIORATION 134 0.0012
359 INTESTINAL PERFORATION 13 0.0012
360 THROMBOSIS 93 0.0012
361 NEUTROPENIA 157 0.0012
362 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
363 DERMATITIS ACNEIFORM 7 0.0011
364 REBOUND EFFECT 13 0.0011
365 HYPOKALAEMIA 53 0.0011
366 PARTIAL SEIZURES 6 0.0011
367 CYANOSIS 18 0.0011
368 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
369 HYPOACUSIS 49 0.0011
370 TASTE DISORDER 23 0.0011
371 ABDOMINAL ABSCESS 5 0.0011
372 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
373 FIBRIN D DIMER INCREASED 4 0.0011
374 LUNG DISORDER 55 0.0011
375 BODY HEIGHT DECREASED 12 0.0011
376 ILEUS PARALYTIC 5 0.0011
377 PRODUCT SIZE ISSUE 6 0.0011
378 NERVOUS SYSTEM DISORDER 34 0.0011
379 RENAL FUNCTION TEST ABNORMAL 5 0.0011
380 INTRACRANIAL PRESSURE INCREASED 6 0.0011
381 PULMONARY MASS 16 0.0011
382 APPENDICITIS 10 0.0011
383 TIBIA FRACTURE 5 0.0011
384 DYSPNOEA EXERTIONAL 40 0.0011
385 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
386 HYPOCALCAEMIA 20 0.0011
387 WEIGHT FLUCTUATION 11 0.0011
388 PRODUCT PRESCRIBING ERROR 25 0.0010
389 PNEUMONIA 339 0.0010
390 TUMOUR MARKER INCREASED 5 0.0010
391 PNEUMONIA ASPIRATION 26 0.0010
392 SUDDEN DEATH 11 0.0010
393 ENTEROCOCCAL INFECTION 5 0.0010
394 RENAL FAILURE 137 0.0010
395 URINE OUTPUT DECREASED 9 0.0010
396 RHINOVIRUS INFECTION 4 0.0010
397 ACUTE HEPATIC FAILURE 14 0.0010
398 LUNG INFILTRATION 9 0.0010
399 HEPATOMEGALY 10 0.0010
400 BREATH SOUNDS ABNORMAL 5 0.0010
401 RENAL DISORDER 47 0.0010
402 BONE MARROW DISORDER 3 0.0010
403 ORGAN FAILURE 4 0.0010
404 HAEMOGLOBIN DECREASED 101 0.0010
405 ERUCTATION 19 0.0010
406 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
407 LARYNGEAL OEDEMA 6 0.0010
408 CELLULITIS 49 0.0010
409 RESPIRATORY DISORDER 29 0.0010
410 TONGUE DISORDER 7 0.0010
411 ERYTHEMA MULTIFORME 9 0.0010
412 BLOOD POTASSIUM DECREASED 29 0.0010
413 BLOOD CREATININE DECREASED 3 0.0010
414 HAEMATOTOXICITY 9 0.0009
415 HYPERKALAEMIA 33 0.0009
416 WHITE BLOOD CELL COUNT DECREASED 102 0.0009
417 PULMONARY TUBERCULOSIS 4 0.0009
418 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
419 BLINDNESS 38 0.0009
420 NODULE 12 0.0009
421 GASTROOESOPHAGEAL REFLUX DISEASE 74 0.0009
422 HYDROCEPHALUS 5 0.0009
423 ASTHENIA 345 0.0009
424 ASPERGILLUS INFECTION 6 0.0009
425 PHOTOSENSITIVITY REACTION 15 0.0009
426 DEAFNESS UNILATERAL 5 0.0009
427 C-REACTIVE PROTEIN INCREASED 33 0.0009
428 COUGH 253 0.0009
429 BLOOD SODIUM DECREASED 17 0.0009
430 NECROSIS 5 0.0009
431 CARDIOTOXICITY 8 0.0009
432 TOXIC SKIN ERUPTION 9 0.0009
433 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
434 ANAEMIA 169 0.0009
435 OSTEONECROSIS 29 0.0009
436 TRICUSPID VALVE INCOMPETENCE 7 0.0009
437 URINE ABNORMALITY 4 0.0009
438 LEUKOPENIA 44 0.0009
439 NEUTROPHIL COUNT INCREASED 9 0.0009
440 NEPHROTIC SYNDROME 6 0.0009
441 MYOCARDITIS 10 0.0009
442 RETINAL DETACHMENT 8 0.0009
443 MULTI-ORGAN FAILURE 15 0.0009
444 PRESYNCOPE 21 0.0009
445 RALES 5 0.0009
446 ASPHYXIA 7 0.0009
447 HICCUPS 7 0.0009
448 NEUROPATHY PERIPHERAL 81 0.0009
449 SKIN TIGHTNESS 4 0.0008
450 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
451 SPINAL COLUMN STENOSIS 4 0.0008
452 PLATELET COUNT INCREASED 11 0.0008
453 ATAXIA 10 0.0008
454 HEMIPLEGIA 7 0.0008
455 HYPERLIPIDAEMIA 10 0.0008
456 THERAPY PARTIAL RESPONDER 13 0.0008
457 PERICARDITIS 14 0.0008
458 THROMBOCYTOPENIA 93 0.0008
459 APHAGIA 4 0.0008
460 GANGRENE 5 0.0008
461 RENAL FAILURE ACUTE 35 0.0008
462 PRODUCT USE ISSUE 155 0.0008
463 UTERINE LEIOMYOMA 6 0.0008
464 VITAMIN D DECREASED 7 0.0008
465 PSEUDOMONAS INFECTION 7 0.0008
466 HYPOTHYROIDISM 26 0.0008
467 HYPOPHOSPHATAEMIA 6 0.0008
468 CEREBRAL DISORDER 6 0.0008
469 CEREBRAL HAEMORRHAGE 29 0.0008
470 DRUG INTERACTION 128 0.0008
471 HEPATIC STEATOSIS 15 0.0008
472 SEPSIS 89 0.0008
473 SPINAL OSTEOARTHRITIS 7 0.0008
474 PATHOLOGICAL FRACTURE 4 0.0008
475 SWELLING 73 0.0008
476 INCREASED UPPER AIRWAY SECRETION 4 0.0008
477 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
478 HAEMATOMA 20 0.0008
479 PYREXIA 267 0.0008
480 PERIORBITAL OEDEMA 4 0.0008
481 RED BLOOD CELL COUNT DECREASED 22 0.0008
482 DYSPNOEA 432 0.0008
483 LYMPHADENOPATHY 27 0.0008
484 PNEUMONIA BACTERIAL 7 0.0008
485 EYE DISORDER 25 0.0008
486 IMMUNE SYSTEM DISORDER 10 0.0008
487 IRON DEFICIENCY ANAEMIA 7 0.0008
488 PRODUCTIVE COUGH 36 0.0008
489 AZOTAEMIA 3 0.0008
490 HEPATIC ENCEPHALOPATHY 7 0.0007
491 LOWER RESPIRATORY TRACT INFECTION 34 0.0007
492 SEIZURE 86 0.0007
493 POSTOPERATIVE WOUND INFECTION 5 0.0007
494 FRACTURE 14 0.0007
495 LYMPHOCYTE COUNT DECREASED 13 0.0007
496 CYTOPENIA 9 0.0007
497 ARTHRITIS BACTERIAL 3 0.0007
498 EYE MOVEMENT DISORDER 5 0.0007
499 JOINT EFFUSION 5 0.0007
500 HYPERCHOLESTEROLAEMIA 7 0.0007
501 DRUG LEVEL INCREASED 12 0.0007
502 HYPOTENSION 145 0.0007
503 GASTRITIS 19 0.0007
504 VENTRICULAR FIBRILLATION 8 0.0007
505 EOSINOPHIL COUNT INCREASED 6 0.0007
506 STREPTOCOCCAL INFECTION 4 0.0007
507 ABDOMINAL DISTENSION 75 0.0007
508 MALAISE 315 0.0007
509 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
510 VITAMIN D DEFICIENCY 7 0.0007
511 HEART RATE ABNORMAL 4 0.0007
512 APHONIA 10 0.0007
513 FATIGUE 557 0.0007
514 THERAPY CHANGE 7 0.0007
515 BODY TEMPERATURE DECREASED 7 0.0007
516 HOSPICE CARE 7 0.0007
517 BUNDLE BRANCH BLOCK LEFT 3 0.0007
518 WEIGHT DECREASED 197 0.0007
519 NEUROLOGICAL SYMPTOM 4 0.0007
520 PARALYSIS 10 0.0007
521 MYOPATHY 6 0.0007
522 VISUAL ACUITY REDUCED 23 0.0007
523 GASTROINTESTINAL DISORDER 62 0.0007
524 COLITIS 26 0.0007
525 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
526 GASTRIC ULCER 13 0.0007
527 HYPOVOLAEMIA 4 0.0007
528 ORAL CANDIDIASIS 9 0.0007
529 TUMOUR LYSIS SYNDROME 6 0.0007
530 CHOLESTASIS 13 0.0007
531 HYPERBILIRUBINAEMIA 7 0.0007
532 ISCHAEMIC STROKE 12 0.0007
533 POLYNEUROPATHY 8 0.0007
534 ANAL INCONTINENCE 6 0.0007
535 SEPTIC SHOCK 29 0.0007
536 BONE PAIN 39 0.0007
537 OROPHARYNGEAL DISCOMFORT 6 0.0007
538 LEUKOCYTOSIS 12 0.0007
539 DELIRIUM 23 0.0007
540 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
541 IMPAIRED GASTRIC EMPTYING 9 0.0007
542 TENSION 4 0.0007
543 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
544 RESPIRATORY DISTRESS 18 0.0007
545 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
546 ENCEPHALOPATHY 16 0.0007
547 CANDIDA INFECTION 11 0.0007
548 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
549 SYNCOPE 65 0.0006
550 HAEMOLYSIS 5 0.0006
551 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
552 FLANK PAIN 6 0.0006
553 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
554 PULMONARY HAEMORRHAGE 5 0.0006
555 ASPIRATION 7 0.0006
556 JOINT SWELLING 77 0.0006
557 DIZZINESS 316 0.0006
558 CARDIAC ARREST 52 0.0006
559 GAIT INABILITY 21 0.0006
560 ATRIAL FLUTTER 5 0.0006
561 SKIN INFECTION 7 0.0006
562 ACUTE KIDNEY INJURY 95 0.0006
563 RHINITIS 5 0.0006
564 BLOOD PRESSURE DECREASED 41 0.0006
565 ATRIAL FIBRILLATION 60 0.0006
566 DYSPHONIA 36 0.0006
567 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
568 ABDOMINAL DISCOMFORT 103 0.0006
569 ABNORMAL FAECES 5 0.0006
570 INTESTINAL OBSTRUCTION 23 0.0006
571 PRODUCT USE IN UNAPPROVED INDICATION 151 0.0006
572 GASTRIC HAEMORRHAGE 7 0.0006
573 DYSGRAPHIA 4 0.0006
574 ABDOMINAL TENDERNESS 3 0.0006
575 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
576 THROAT IRRITATION 27 0.0006
577 SALIVARY HYPERSECRETION 6 0.0006
578 RHABDOMYOLYSIS 25 0.0006
579 CHOLECYSTITIS CHRONIC 4 0.0006
580 HYPOAESTHESIA ORAL 9 0.0006
581 BREAST MASS 4 0.0006
582 JAUNDICE 16 0.0006
583 BRONCHIECTASIS 4 0.0006
584 SENSATION OF FOREIGN BODY 5 0.0006
585 DRY THROAT 6 0.0006
586 HEMIPARESIS 10 0.0006
587 BACTERAEMIA 7 0.0006
588 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
589 DRUG LEVEL DECREASED 6 0.0006
590 SUBARACHNOID HAEMORRHAGE 6 0.0006
591 BODY TEMPERATURE INCREASED 12 0.0006
592 FACIAL PARALYSIS 5 0.0006
593 THERAPY CESSATION 30 0.0006
594 RESPIRATION ABNORMAL 4 0.0006
595 PROTEINURIA 11 0.0006
596 DEAFNESS 15 0.0006
597 SPEECH DISORDER 30 0.0006
598 BLOOD TEST ABNORMAL 8 0.0006
599 JOINT DISLOCATION 6 0.0006
600 FULL BLOOD COUNT ABNORMAL 6 0.0006
601 EAR PAIN 11 0.0006
602 FLATULENCE 32 0.0006
603 ABSCESS 9 0.0006
604 RETCHING 12 0.0006
605 HYPOAESTHESIA 84 0.0006
606 DRUG INTOLERANCE 54 0.0006
607 HAEMOLYTIC ANAEMIA 5 0.0006
608 TOOTHACHE 10 0.0006
609 OPTIC NEURITIS 5 0.0005
610 CHOKING SENSATION 3 0.0005
611 BLINDNESS TRANSIENT 4 0.0005
612 UROSEPSIS 5 0.0005
613 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
614 VERTIGO 33 0.0005
615 OFF LABEL USE 474 0.0005
616 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
617 SWELLING FACE 35 0.0005
618 DEMENTIA 15 0.0005
619 NEURALGIA 13 0.0005
620 MUSCULOSKELETAL PAIN 28 0.0005
621 CHROMATURIA 12 0.0005
622 WEIGHT INCREASED 119 0.0005
623 MITRAL VALVE INCOMPETENCE 6 0.0005
624 CHOLECYSTITIS ACUTE 3 0.0005
625 PULMONARY HYPERTENSION 11 0.0005
626 BLOOD COUNT ABNORMAL 8 0.0005
627 CHEST PAIN 97 0.0005
628 INCREASED APPETITE 10 0.0005
629 INFLAMMATION 27 0.0005
630 BOWEL MOVEMENT IRREGULARITY 4 0.0005
631 NEOPLASM 6 0.0005
632 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
633 SPINAL PAIN 6 0.0005
634 ABDOMINAL PAIN 119 0.0005
635 SKIN LESION 14 0.0005
636 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
637 ACUTE MYOCARDIAL INFARCTION 15 0.0005
638 DRUG ERUPTION 9 0.0005
639 PLATELET COUNT DECREASED 54 0.0005
640 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
641 LOSS OF CONSCIOUSNESS 64 0.0005
642 RESPIRATORY TRACT INFECTION 13 0.0005
643 UTERINE CANCER 4 0.0005
644 BALANCE DISORDER 43 0.0005
645 SENSORY LOSS 4 0.0005
646 EMPHYSEMA 5 0.0005
647 EYELID PTOSIS 5 0.0005
648 INTENTIONAL PRODUCT MISUSE 43 0.0005
649 ABDOMINAL PAIN UPPER 101 0.0005
650 PANCREATITIS ACUTE 11 0.0005
651 CARDIOMEGALY 6 0.0005
652 RIB FRACTURE 10 0.0005
653 ABASIA 12 0.0005
654 ACUTE CORONARY SYNDROME 4 0.0005
655 PERITONITIS 10 0.0005
656 VIRAL INFECTION 16 0.0005
657 COAGULOPATHY 8 0.0005
658 URINARY RETENTION 16 0.0005
659 SECRETION DISCHARGE 6 0.0005
660 RASH 208 0.0005
661 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
662 MUSCLE ATROPHY 6 0.0005
663 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
664 COGNITIVE DISORDER 22 0.0005
665 CONFUSIONAL STATE 76 0.0005
666 IMMUNODEFICIENCY 7 0.0005
667 HIP FRACTURE 15 0.0005
668 EPILEPSY 14 0.0005
669 MUSCULAR WEAKNESS 52 0.0005
670 INFECTION 66 0.0005
671 GROIN PAIN 4 0.0005
672 PULMONARY CONGESTION 6 0.0005
673 PHARYNGEAL OEDEMA 7 0.0005
674 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
675 ANGINA PECTORIS 13 0.0005
676 EJECTION FRACTION DECREASED 7 0.0004
677 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
678 MALIGNANT MELANOMA 6 0.0004
679 BACK PAIN 104 0.0004
680 PRODUCT PHYSICAL ISSUE 9 0.0004
681 UVEITIS 6 0.0004
682 LIMB INJURY 12 0.0004
683 ULCER 7 0.0004
684 CARDIAC DISORDER 41 0.0004
685 PERIPHERAL COLDNESS 6 0.0004
686 MOVEMENT DISORDER 14 0.0004
687 HAEMATEMESIS 11 0.0004
688 OVARIAN CANCER 4 0.0004
689 APHASIA 13 0.0004
690 EYELID OEDEMA 5 0.0004
691 BACTERIAL INFECTION 8 0.0004
692 DIARRHOEA HAEMORRHAGIC 4 0.0004
693 MOUTH ULCERATION 9 0.0004
694 OXYGEN SATURATION DECREASED 24 0.0004
695 STAPHYLOCOCCAL INFECTION 14 0.0004
696 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
697 SINUS TACHYCARDIA 6 0.0004
698 MEMORY IMPAIRMENT 58 0.0004
699 BLOOD URINE PRESENT 8 0.0004
700 BLOOD IRON DECREASED 5 0.0004
701 FEMUR FRACTURE 13 0.0004
702 SKIN DISORDER 14 0.0004
703 CHOLECYSTITIS 5 0.0004
704 CEREBROVASCULAR ACCIDENT 71 0.0004
705 HYPERTHYROIDISM 6 0.0004
706 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
707 ADRENAL INSUFFICIENCY 5 0.0004
708 MELAENA 9 0.0004
709 CARDIOMYOPATHY 6 0.0004
710 OSTEONECROSIS OF JAW 10 0.0004
711 OVARIAN CYST 4 0.0004
712 OROPHARYNGEAL PAIN 37 0.0004
713 SPINAL FRACTURE 8 0.0004
714 HEAD DISCOMFORT 7 0.0004
715 GAIT DISTURBANCE 75 0.0004
716 INTRAOCULAR PRESSURE INCREASED 5 0.0004
717 LYMPHOMA 6 0.0004
718 ATRIOVENTRICULAR BLOCK 3 0.0004
719 GASTROENTERITIS VIRAL 7 0.0004
720 ANKLE FRACTURE 6 0.0004
721 HIATUS HERNIA 5 0.0004
722 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
723 APNOEA 3 0.0004
724 VENTRICULAR EXTRASYSTOLES 4 0.0004
725 BONE DISORDER 7 0.0004
726 DERMATITIS 8 0.0004
727 PARAESTHESIA 60 0.0004
728 PRODUCT USE COMPLAINT 6 0.0004
729 DIABETES MELLITUS 29 0.0004
730 HAEMATURIA 13 0.0004
731 CONJUNCTIVITIS 7 0.0004
732 ADVERSE REACTION 5 0.0004
733 QUALITY OF LIFE DECREASED 5 0.0004
734 FAECES DISCOLOURED 8 0.0004
735 TACHYPNOEA 5 0.0004
736 SLEEP APNOEA SYNDROME 7 0.0004
737 BRONCHITIS 27 0.0004
738 GASTROINTESTINAL PAIN 4 0.0004
739 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
740 RESPIRATORY ARREST 10 0.0004
741 MENTAL STATUS CHANGES 10 0.0004
742 PANCREATITIS 19 0.0004
743 FEELING COLD 10 0.0004
744 CHOKING 7 0.0004
745 ORAL PAIN 8 0.0004
746 CARPAL TUNNEL SYNDROME 5 0.0004
747 HYPERGLYCAEMIA 13 0.0004
748 KIDNEY INFECTION 7 0.0004
749 NEPHROPATHY TOXIC 4 0.0004
750 SKIN REACTION 5 0.0004
751 HEART RATE IRREGULAR 8 0.0004
752 SINUS DISORDER 7 0.0004
753 DISORIENTATION 14 0.0004
754 CATARACT 21 0.0004
755 IMPAIRED DRIVING ABILITY 4 0.0004
756 MYOCARDIAL ISCHAEMIA 4 0.0004
757 UPPER LIMB FRACTURE 7 0.0004
758 BRONCHOSPASM 5 0.0004
759 GASTRIC DISORDER 12 0.0003
760 ANURIA 3 0.0003
761 FALL 116 0.0003
762 TINNITUS 16 0.0003
763 MENTAL DISORDER 15 0.0003
764 HAEMATOCHEZIA 19 0.0003
765 EOSINOPHILIA 6 0.0003
766 COVID-19 60 0.0003
767 URINARY INCONTINENCE 10 0.0003
768 WHEEZING 20 0.0003
769 COLON CANCER 5 0.0003
770 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
771 ACCIDENT 4 0.0003
772 CARDIO-RESPIRATORY ARREST 14 0.0003
773 OSTEOMYELITIS 6 0.0003
774 LETHARGY 19 0.0003
775 PAIN IN EXTREMITY 97 0.0003
776 CONDITION AGGRAVATED 100 0.0003
777 SMALL INTESTINAL OBSTRUCTION 4 0.0003
778 DEVICE RELATED INFECTION 5 0.0003
779 DIVERTICULITIS 9 0.0003
780 SPINAL OPERATION 4 0.0003
781 CARDIAC FAILURE CONGESTIVE 26 0.0003
782 LIMB DISCOMFORT 10 0.0003
783 AMNESIA 21 0.0003
784 CYST 4 0.0003
785 DRY EYE 16 0.0003
786 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
787 HEPATIC CIRRHOSIS 6 0.0003
788 POISONING 4 0.0003
789 ARRHYTHMIA 15 0.0003
790 URINARY TRACT INFECTION 54 0.0003
791 HAEMORRHAGE 33 0.0003
792 DISEASE RECURRENCE 15 0.0003
793 CARDIOVASCULAR DISORDER 8 0.0003
794 TOOTH DISORDER 7 0.0003
795 CONVULSION 18 0.0003
796 HYPERSOMNIA 9 0.0003
797 HERPES ZOSTER 18 0.0003
798 LOWER LIMB FRACTURE 6 0.0003
799 SNEEZING 7 0.0003
800 GLAUCOMA 6 0.0003
801 ILLNESS 32 0.0003
802 HYPOGLYCAEMIA 15 0.0003
803 MYALGIA 52 0.0003
804 CHOLELITHIASIS 10 0.0003
805 HEADACHE 191 0.0003
806 HEART RATE INCREASED 30 0.0003
807 TREATMENT FAILURE 25 0.0003
808 BRAIN INJURY 3 0.0003
809 FULL BLOOD COUNT DECREASED 6 0.0003
810 COMA 14 0.0003
811 PALLOR 8 0.0003
812 CIRCULATORY COLLAPSE 5 0.0003
813 NASOPHARYNGITIS 54 0.0003
814 HALLUCINATION 22 0.0003
815 BLOOD PRESSURE FLUCTUATION 7 0.0003
816 PAIN 178 0.0003
817 MENTAL IMPAIRMENT 7 0.0003
818 MASS 4 0.0003
819 NEUROTOXICITY 5 0.0003
820 HALLUCINATION, VISUAL 6 0.0003
821 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
822 TACHYCARDIA 25 0.0003
823 BLOOD PRESSURE INCREASED 43 0.0003
824 SUBDURAL HAEMATOMA 4 0.0003
825 BREAST CANCER METASTATIC 3 0.0003
826 INSOMNIA 74 0.0003
827 RASH PRURITIC 15 0.0003
828 MYOCARDIAL INFARCTION 48 0.0003
829 DYSSTASIA 8 0.0003
830 BLOOD GLUCOSE FLUCTUATION 3 0.0003
831 RASH GENERALISED 7 0.0003
832 RASH MACULO-PAPULAR 6 0.0003
833 INFLUENZA 30 0.0003
834 MIDDLE INSOMNIA 5 0.0003
835 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
836 CHEST DISCOMFORT 27 0.0003
837 MUSCULOSKELETAL DISORDER 5 0.0003
838 SHOCK 6 0.0003
839 POST PROCEDURAL COMPLICATION 5 0.0003
840 MUSCLE TWITCHING 6 0.0003
841 BURNING SENSATION 18 0.0003
842 MENINGIOMA 4 0.0003
843 BLOOD PRESSURE ABNORMAL 5 0.0003
844 CYSTITIS 8 0.0003
845 RASH ERYTHEMATOUS 12 0.0003
846 SCIATICA 4 0.0003
847 PANCYTOPENIA 14 0.0003
848 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
849 SENSORY DISTURBANCE 4 0.0002
850 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
851 PAIN IN JAW 7 0.0002
852 DYSKINESIA 10 0.0002
853 DEPRESSED MOOD 13 0.0002
854 DISCOMFORT 15 0.0002
855 INTENTIONAL DOSE OMISSION 7 0.0002
856 MUSCLE SPASMS 45 0.0002
857 IMPAIRED HEALING 8 0.0002
858 EYE SWELLING 9 0.0002
859 CYTOMEGALOVIRUS INFECTION 4 0.0002
860 FUNGAL INFECTION 8 0.0002
861 NEPHROLITHIASIS 11 0.0002
862 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
863 SKIN DISCOLOURATION 11 0.0002
864 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
865 ABDOMINAL PAIN LOWER 6 0.0002
866 LABORATORY TEST ABNORMAL 7 0.0002
867 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
868 GASTRIC CANCER 6 0.0002
869 RECTAL HAEMORRHAGE 10 0.0002
870 UNRESPONSIVE TO STIMULI 6 0.0002
871 HYPERTENSION 49 0.0002
872 PRODUCT DISPENSING ERROR 5 0.0002
873 PRODUCT PRESCRIBING ISSUE 5 0.0002
874 SOMNOLENCE 46 0.0002
875 FEELING HOT 14 0.0002
876 BEDRIDDEN 3 0.0002
877 SLEEP DISORDER 16 0.0002
878 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
879 ALOPECIA 44 0.0002
880 THERAPY NON-RESPONDER 10 0.0002
881 FREQUENT BOWEL MOVEMENTS 6 0.0002
882 CHILLS 26 0.0002
883 PELVIC PAIN 4 0.0002
884 MOOD ALTERED 6 0.0002
885 DYSURIA 8 0.0002
886 POLLAKIURIA 9 0.0002
887 THINKING ABNORMAL 4 0.0002
888 EYE PAIN 12 0.0002
889 HOT FLUSH 16 0.0002
890 DRUG DOSE OMISSION 35 0.0002
891 FOOT FRACTURE 4 0.0002
892 DRY SKIN 28 0.0002
893 DRY MOUTH 17 0.0002
894 ANOSMIA 3 0.0002
895 HERNIA 4 0.0002
896 ARTHRALGIA 86 0.0002
897 ANGIOEDEMA 9 0.0002
898 PSYCHOTIC DISORDER 6 0.0002
899 EPISTAXIS 15 0.0002
900 NECK PAIN 11 0.0002
901 TOXICITY TO VARIOUS AGENTS 33 0.0002
902 EMOTIONAL DISORDER 6 0.0002
903 BRAIN FOG 3 0.0002
904 INTENTIONAL DRUG MISUSE 4 0.0002
905 PRURITUS 73 0.0002
906 OCULAR HYPERAEMIA 9 0.0002
907 NIGHT SWEATS 6 0.0002
908 DYSARTHRIA 7 0.0002
909 POOR QUALITY SLEEP 4 0.0002
910 RHINORRHOEA 12 0.0002
911 ERYTHEMA 38 0.0002
912 THROAT TIGHTNESS 5 0.0002
913 BACK DISORDER 3 0.0002
914 PRODUCT DOSE OMISSION 12 0.0002
915 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
916 THERAPY INTERRUPTED 13 0.0002
917 MOBILITY DECREASED 13 0.0002
918 TREMOR 30 0.0002
919 LIP SWELLING 6 0.0002
920 FEELING ABNORMAL 43 0.0002
921 BLOOD GLUCOSE INCREASED 33 0.0002
922 NERVOUSNESS 9 0.0002
923 RASH MACULAR 6 0.0002
924 DRUG INEFFECTIVE 226 0.0002
925 RENAL INJURY 5 0.0002
926 DEPRESSION 38 0.0002
927 PREMATURE BABY 5 0.0002
928 HOSPITALISATION 25 0.0002
929 AGRANULOCYTOSIS 3 0.0002
930 ACNE 12 0.0002
931 HEAD INJURY 5 0.0002
932 SINUSITIS 16 0.0002
933 ERECTILE DYSFUNCTION 4 0.0002
934 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
935 BLOOD CHOLESTEROL INCREASED 7 0.0002
936 THERAPEUTIC RESPONSE DECREASED 9 0.0001
937 HYPERSENSITIVITY 27 0.0001
938 ADVERSE DRUG REACTION 13 0.0001
939 WOUND 4 0.0001
940 ANXIETY 40 0.0001
941 PANCREATIC CARCINOMA 4 0.0001
942 ACCIDENTAL OVERDOSE 5 0.0001
943 RESTLESSNESS 5 0.0001
944 AGITATION 10 0.0001
945 NASAL CONGESTION 8 0.0001
946 OESOPHAGEAL CARCINOMA 4 0.0001
947 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
948 SKIN EXFOLIATION 11 0.0001
949 SWOLLEN TONGUE 4 0.0001
950 INFLUENZA LIKE ILLNESS 10 0.0001
951 ROAD TRAFFIC ACCIDENT 5 0.0001
952 OSTEOARTHRITIS 5 0.0001
953 ANAPHYLACTIC SHOCK 3 0.0001
954 ECZEMA 6 0.0001
955 MUSCULOSKELETAL STIFFNESS 10 0.0001
956 INJURY 8 0.0001
957 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
958 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
959 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
960 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
961 PALPITATIONS 13 0.0001
962 ARTHROPATHY 6 0.0001
963 BLISTER 6 0.0001
964 UNEVALUABLE EVENT 8 0.0001
965 PRODUCT DOSE OMISSION ISSUE 31 0.0001
966 CHRONIC KIDNEY DISEASE 8 0.0001
967 PLASMA CELL MYELOMA 4 0.0001
968 ARTHRITIS 8 0.0001
969 ABNORMAL BEHAVIOUR 4 0.0001
970 AGGRESSION 5 0.0001
971 ADVERSE EVENT 9 0.0001
972 BREAST CANCER 9 0.0001
973 CONTUSION 9 0.0001
974 PRODUCT QUALITY ISSUE 12 0.0001
975 HYPERHIDROSIS 11 0.0001
976 IRRITABILITY 5 0.0001
977 ILL-DEFINED DISORDER 5 0.0001
978 FLUSHING 8 0.0001
979 NO ADVERSE EVENT 14 0.0001
980 PROSTATE CANCER 6 0.0001
981 DISTURBANCE IN ATTENTION 4 0.0001
982 ASTHMA 8 0.0001
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
984 EYE IRRITATION 4 0.0001
985 SURGERY 4 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
987 BLOOD GLUCOSE DECREASED 3 0.0001
988 COMPLETED SUICIDE 5 0.0001
989 SKIN BURNING SENSATION 4 0.0001
990 URTICARIA 9 0.0001
991 RHEUMATOID ARTHRITIS 6 0.0001
992 OVERDOSE 11 0.0001
993 INCORRECT DOSE ADMINISTERED 9 0.0000
994 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
995 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000